aTyr Pharma in the spotlight
Recent financing and future outlook
aTyr Pharma (LIFE) announced a financing yesterday that diluted the company by approximately 45%. LIFE offered 22.225M shares of stock at a price of $2.25 to raise $50M, before any expenses. The offering was announced after LIFE had also received a $10M milestone from their Japanese partner Kyroin. After the financing, LIFE has 52M shares outstanding, a…